Penumbra, Inc.
Penumbra, Inc. (PEN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PEN · as of Jun 8, 2026
Key Statistics
Explore Penumbra, Inc. Data
pen stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 22 · Buy rate: 40.9%
The PEN analyst consensus is Hold, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $369.83, representing +15.30% upside from the current price of $320.77.
Competitors & Peers
pen competitorsPEN
ALGN
BAX
BIO
CRL
DVAStock Performance
Full HistoryAbout Penumbra, Inc.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, in…
what is penumbra, inc. · pen stock overview · penumbra, inc. company profile · who is penumbra, inc. ceo · pen NYSE · penumbra, inc. headquarters · penumbra, inc. business segments
About Stock Overview & Key Data
Penumbra, Inc. (PEN) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Sep 18, 2015. As of the latest trading session, PEN stock price is $320.77, with a market capitalization of $12.6B. The stock has returned +25.12% over the past 12 months and +3.22% year-to-date.
According to 22 Wall Street analysts, the consensus rating for Penumbra, Inc. stock is Hold, with an average 12-month price target of $369.83. In fiscal year 2025, Penumbra, Inc. reported revenue of $1.4B and net income of $177.7M. For detailed data — including Penumbra, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Penumbra, Inc. (PEN) stock price is $320.77. The stock is traded on NYSE under the ticker symbol PEN. The 52-week range is $221.26 – $362.41.